Compounds and their salts specific to the PPAR receptors and the EGF receptors and their use in the medical field
The present invention relates to compounds comprising the general formula (I), in which R 1 and R 2 , which may be identical or different, are selected from the group comprising —H or a linear or branched alkyl group having from 1 to 6 carbon atoms or together form an aromatic or aliphatic ring with 5 or 6 atoms; Y and Z, which may be identical or different, are selected from the group comprising —H, —OH, —COOH, —OR 3 , —CH(OR 3 )COOH, in which R 3 is selected from H, phenyl, benzyl, —CF 3 or —CF 2 CF 3 , vinyl, allyl and a linear or branched alkyl group having from 1 to 6 carbon atoms.
1. A compound of the general formula (I)
in which
R 1 and R 2 , which may be identical or different, are selected from the group consisting of —H or a linear or branched alkyl group having from 1 to 6 carbon atoms or together form an aromatic or aliphatic ring with 5 or 6 atoms;
Y is selected from the group consisting of —H, —OH, —COOH, —OR 3 , —CH(OR 3 )COOH, in which R 3 is selected from phenyl, benzyl, —CF 3 or —CF 2 CF 3 , vinyl, allyl and a linear or branched alkyl group having from 1 to 6 carbon atoms;
Z is selected from the group consisting of, —CH(OR 3 )COOH, in which R 3 is selected from phenyl, benzyl, —CF 3 or —CF 2 CF 3 , vinyl, allyl and a linear or branched alkyl group having from 1 to 6 carbon atoms; wherein —NR 1 R 2 is bonded at the 4-position;
and salts thereof.
2. A compound of claim 1 of the general formula (Ia)
in which
R 1 and R 2 , which may be identical or different, are selected from the group consisting of —H or a linear or branched alkyl group having from 1 to 6 carbon atoms;
Y is selected from the group consisting of —H, —OH, —OR 3 , —CH(OR 3 )COOH, in which R 3 is selected from a linear or branched alkyl group having from 1 to 6 carbon atoms; and
Z is —CH(OR 3 )COOH, in which R 3 is selected from phenyl, benzyl, —CF 3 or —CF 2 CF 3 , vinyl, allyl and a linear or branched alkyl group having from 1 to 6 carbon atoms.
3. A compound as claimed in claim 1 wherein the linear or branched alkyl group having from 1 to 6 carbon atoms is selected from —CH 3 , —CH 2 CH 3 , —CH(CH 3 ) 2 , and —CH 2 CH 2 CH 3 .
4. A compound as claimed in claim 1 wherein Y is H.
5. A compound as claimed in claim 1 wherein Z is —CH(OR 3 )COOH.
6. A compound as claimed in claim 1 wherein R 3 is —CH 3 .
7. A compound as claimed in claim 1 according to the following formula:
8. A compound according to the following formula:
9. A compound as claimed in claim 1 wherein R 3 is —CH 2 CH 3 .
10. A compound as claimed in claim 1 according to the following formula
11. A compound according to the following formula
12. A compound according to the following formula
13. A compound according to the following formula
14. A compound according to the following formula
15. A compound according to claim 1 in enantiomerically pure R or S form.
16. A pharmaceutical composition comprising one or more compounds as defined in claim 1 as active principles in combination with one or more pharmaceutically acceptable excipients or adjuvants.
17. A compound represented by:
or salts thereof.
18. A pharmaceutical composition comprising a compound of claim 17 and a pharmaceutically acceptable excipient.
19. The compound of claim 17 in an enantiomerically pure R or S form.